(4R,6S,9aR)-6-((S)-2-Mercapto-3-phenyl-propionylamino)-5-oxo-octahydro-1-thia-4a-aza-benzocycloheptene-4-carboxylic acid

ID: ALA165061

PubChem CID: 44377612

Max Phase: Preclinical

Molecular Formula: C19H24N2O4S2

Molecular Weight: 408.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)[C@H]1CCS[C@@H]2CCC[C@H](NC(=O)[C@@H](S)Cc3ccccc3)C(=O)N12

Standard InChI:  InChI=1S/C19H24N2O4S2/c22-17(15(26)11-12-5-2-1-3-6-12)20-13-7-4-8-16-21(18(13)23)14(19(24)25)9-10-27-16/h1-3,5-6,13-16,26H,4,7-11H2,(H,20,22)(H,24,25)/t13-,14+,15-,16+/m0/s1

Standard InChI Key:  HSNXSUNHPADRNW-XUWVNRHRSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  1  0  0  0  0  0999 V2000
    6.6125   -2.4042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0417   -2.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9917   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5042   -2.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0250   -2.5542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8250   -1.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5417   -2.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7750   -3.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4167   -1.7417    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.9792   -2.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9500   -3.1792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5042   -1.6542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1792   -3.5292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9792   -3.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5875   -2.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4625   -2.2542    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.8000   -2.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1542   -3.8917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4625   -3.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5000   -1.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5292   -1.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9417   -1.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417   -3.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4667   -4.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9500   -4.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4250   -3.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4250   -4.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1250   -1.3167    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  5  1  0
  7  5  1  1
  6  1  1  0
  7  2  1  0
  3  8  1  6
  9  6  1  0
 10  4  1  0
 11  2  2  0
 12  4  2  0
 13  8  2  0
 10 14  1  6
 15  3  1  0
 16 10  1  0
 17  9  1  0
 18  8  1  0
 19 14  1  0
 20  7  1  0
 21  6  1  0
 22 21  1  0
 23 19  2  0
 24 19  1  0
 25 24  2  0
 26 23  1  0
 27 25  1  0
  6 28  1  6
 22 20  1  0
 17 15  1  0
 27 26  2  0
M  END

Associated Targets(non-human)

Mme Neprilysin (537 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ace Angiotensin-converting enzyme (1080 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.55Molecular Weight (Monoisotopic): 408.1177AlogP: 1.94#Rotatable Bonds: 5
Polar Surface Area: 86.71Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.77CX Basic pKa: CX LogP: 2.06CX LogD: -1.22
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.65Np Likeness Score: -0.10

References

1. Slusarchyk WA, Robl JA, Taunk PC, Assad MM, Bird J, DiMarco J, Pan Y.  (1995)  Dual metalloprotease inhibitors.v. Utilization of bicyclic azepinonethiazolidines and azepinonetetrahydrothiazines in constrained peptidomimetics of mercaptoacyl dipeptides,  (7): [10.1016/0960-894X(95)00109-7]

Source